Fielmann (FIE) AI Stock Analysis

• Market Cap: €3.61B
• Dividend Yield: 2.69%
• Average Volume (3M): 63.96K
• Price to Earnings (P/E): 20.7
• Beta (1Y): 0.70
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: DE
• Employees: 20,221
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.62
• Shares Outstanding: 84,000,000
• 10 Day Avg. Volume: 37,023
• 30 Day Avg. Volume: 63,960
• PEG Ratio: 1.06
• Price to Book (P/B): 3.87
• Price to Sales (P/S): 1.54
• P/FCF Ratio: 10.62
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €64.00
• Price Target Upside: 49.01% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): 2.71
• Revenue Forecast (FY): €2.58B

• Rating: 62 Neutral
• Price Target: €51.00 ▲(18.74% Upside)
• Action: Reiterated Date: 11/19/25
• Date: Action: Reiterated 11/19/25

Fielmann's overall stock score of 62 is primarily driven by strong financial performance, with notable revenue and cash flow growth, though tempered by moderate balance sheet risks. Weak technical indicators reflect bearish momentum, while valuation remains fair with a reasonable P/E ratio and decent dividend yield.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand and effective business strategies, supporting long-term sustainability and expansion.

Negative Factors

Rising Leverage

Increased leverage can heighten financial risk, potentially impacting the company's ability to invest in growth and manage economic downturns.

Fielmann Business Overview & Revenue Model

Company Description

Fielmann Aktiengesellschaft, together with its subsidiaries, engages in the investment in and operation of optical and hearing aid businesses. The company manufactures and sells visual aids and other optical products, including glasses, frames, le...

Read more

Fielmann Aktiengesellschaft, together with its subsidiaries, engages in the investment in and operation of optical and hearing aid businesses. The company manufactures and sells visual aids and other optical products, including glasses, frames, le...

How the Company Makes Money

Fielmann generates revenue primarily through the sale of eyewear products, including prescription glasses, sunglasses, and contact lenses. The company operates a retail model, where customers can purchase products directly from their stores or onl...

Read more

Fielmann generates revenue primarily through the sale of eyewear products, including prescription glasses, sunglasses, and contact lenses. The company operates a retail model, where customers can purchase products directly from their stores or onl...

Fielmann Financial Statement Overview

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Mar 2021
Income Statement
Total Revenue	1.79B	2.26B	1.97B	1.76B	1.68B	1.43B
Gross Profit	1.44B	1.81B	1.57B	1.38B	1.34B	1.15B
EBITDA	341.88M	475.73M	399.17M	346.99M	389.78M	328.70M
Net Income	130.32M	152.11M	127.64M	103.66M	136.85M	116.41M
Balance Sheet
Total Assets	2.39B	2.37B	1.99B	1.77B	1.74B	1.67B
Cash, Cash Equivalents and Short-Term Investments	287.03M	101.68M	81.83M	149.87M	235.54M	221.24M
Total Debt	548.74M	873.85M	592.15M	505.66M	458.26M	425.72M
Total Liabilities	1.42B	1.46B	1.06B	909.10M	863.09M	832.86M
Stockholders Equity	957.51M	899.13M	867.65M	804.22M	819.83M	779.20M
Cash Flow
Free Cash Flow	0.00	327.41M	196.00M	182.69M	260.15M	188.40M
Operating Cash Flow	0.00	410.09M	282.79M	268.08M	346.69M	278.47M
Investing Cash Flow	0.00	-331.17M	-143.25M	-159.85M	-74.85M	-219.67M
Financing Cash Flow	0.00	-44.27M	-132.00M	-209.22M	-201.22M	-85.42M

Fielmann Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 42.95
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:FIE, the sentiment is Negative. The current price of 42.95 is below the 20-day moving average (MA) of 43.73, above the 50-day MA of 42.83, and below the 200-day MA of 48.46, indicating a neutral trend. The MACD of -0.04 indicates Positive momentum. The RSI at 49.33 is Neutral, neither overbought nor oversold. The STOCH value of 50.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:FIE.

Fielmann Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AFX	65 Neutral	€2.14B	17.81	6.77%	1.50%	7.82%	-19.80%
FIE	62 Neutral	€3.61B	20.73	19.74%	2.69%	―	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%